Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.30)
# 4,052
Out of 4,829 analysts
24
Total ratings
33.33%
Success rate
-29.67%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $36.67 | +58.17% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $4.75 | +447.37% | 2 | Mar 13, 2025 | |
| ZYXI Zynex | Downgrades: Neutral | n/a | $2.14 | - | 2 | Mar 12, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.00 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $2.03 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $4.17 | +1,028.45% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $2.54 | +14,191.34% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.66 | +5,321.69% | 1 | Aug 4, 2022 | |
| HROW Harrow | Initiates: Buy | $14 | $26.65 | -46.53% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.26 | +457.77% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $5.45 | +854.13% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $551,250 | $0.91 | +60,891,317.21% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.75 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $60.09 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $36.67
Upside: +58.17%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $4.75
Upside: +447.37%
Zynex
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.14
Upside: -
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.00
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.03
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $4.17
Upside: +1,028.45%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $2.54
Upside: +14,191.34%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.66
Upside: +5,321.69%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $26.65
Upside: -46.53%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.26
Upside: +457.77%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $5.45
Upside: +854.13%
Jun 26, 2020
Initiates: Buy
Price Target: $551,250
Current: $0.91
Upside: +60,891,317.21%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $5.75
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $60.09
Upside: -